Shipra Gandhi, MD, MS

Background

A board-certified medical oncologist, Shipra Gandhi, MD, MS, treats patients with breast cancer at Winship Cancer Institute's Clifton campus. As a physician-scientist, her research interest is in studying immunosuppression in the tumor microenvironment and developing strategies to overcome it in triple-negative breast cancer, an aggressive type of breast cancer.

Dr. Gandhi is an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Before joining Emory, she was on faculty and an attending physician at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

Dr. Gandhi received her medical degree from Lady Hardinge Medical College in New Delhi, India. She completed her internal medicine residency at The State University of New York (SUNY), followed by her fellowship in hematology and oncology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. She also earned a Master of Science from The State University of New York (SUNY)

Titles & Roles

• Associate Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine
• Director of Breast Translational Research, Glenn Family Breast Center

  Winship Cancer Institute of Emory University

Education & Training

Education

• Professional Education, MS, Epidemiology, 2024

  SUNY - Buffalo, School of Med & Biomedical Studies
• Fellowship, Hematology/Oncology, 2018

  Roswell Park Cancer Institute
• Residency, Internal Medicine, 2015

  SUNY - Buffalo, School of Med & Biomedical Studies
• Internship, 2010

  Lady Hardinge Medical College & Associated Hospitals
• Medical Education, MD, 2010

  University of New Delhi

Board Certifications

• Medical Oncology

  American Board of Internal Medicine, 2018
• Hematology

  American Board of Internal Medicine, 2018
• Internal Medicine

  American Board of Internal Medicine, 2015

Professional Memberships

• American Society of Clinical Oncology
• American College of Physicians
• Society for Immunotherapy of Cancer

Research

Dr. Gandhi's research focuses on immunosuppression in the tumor microenvironment and on developing strategies to overcome it in triple-negative breast cancer, an aggressive and deadly subtype.

Publications

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.